drugset / Trial / NCT03603197

BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer

NCT03603197 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether BP-C1 is effective in the short-term treatment of metastatic breast cancer patients who have previously undergone at least three lines of chemotherapy.

Timeline

Start
2014-06-05
Primary completion
2016-08-30
Completion
2016-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject BP-C1 Other / unclassified 0.035 mg/kg Intramuscular

Indications